 |
humanized monoclonal antibody against human PD-1 |
|---|---|
| Trade Name | |
| Orphan Indication | Neuroendocrine tumors |
| USA Market Approval | USA |
| USA Designation Date | 2017-06-08 00:00:00 |
| Sponsor | Novartis Pharmaceuticals Corporation;One Health Plaza, Bldg. 135-566G;East Hanover, New Jersey, 07936 |
